These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3092099)

  • 21. The liver in systemic lupus erythematosus.
    Miller MH; Urowitz MB; Gladman DD; Blendis LM
    Q J Med; 1984; 53(211):401-9. PubMed ID: 6484120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Random urine bile acids in prediction of liver abnormality in asymptomatic alcoholics.
    Simko V; Ferris RK; Michael S; Zachary K
    Arch Intern Med; 1988 Feb; 148(2):312-5. PubMed ID: 3277561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan.
    Huang MC; Chen CH; Yu JM; Chen CC
    Addict Biol; 2005 Sep; 10(3):289-92. PubMed ID: 16109592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Streptokinase in acute myocardial infarction.
    Acta Med Scand Suppl; 1981; 648():1-117. PubMed ID: 7027753
    [No Abstract]   [Full Text] [Related]  

  • 27. [Isoenzymes of alanine- and aspartate transferase and alkaline phosphatase of the blood serum in patients with infectious hepatitis].
    Fedianin IuP
    Klin Med (Mosk); 1969 Jan; 47(1):107-11. PubMed ID: 4890468
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experiences with the new antirheumatic diclofenac].
    Tanner E; Wächter G; Lasarof I; Gaida P
    Z Gesamte Inn Med; 1982 Jan; 37(1):8-12. PubMed ID: 7041447
    [No Abstract]   [Full Text] [Related]  

  • 29. [New normal values of the serum transaminases (determined by using optimized test deposits)].
    Susić D
    Hippokrates; 1970 Dec; 41(4):525-30. PubMed ID: 5496345
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum enzyme pattern in different types of diabetes.
    Khattab M; Zaki AH; el Kammah BM; Madwar K
    J Egypt Med Assoc; 1967; 50(4):253-61. PubMed ID: 4864086
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
    Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients.
    Kim SW; Grant JE; Yoon G; Williams KA; Remmel RP
    Clin Neuropharmacol; 2006; 29(2):77-9. PubMed ID: 16614539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in transaminases over the course of a 12-week, double-blind nalmefene trial in a 38-year-old female subject.
    Salvato FR; Mason BJ
    Alcohol Clin Exp Res; 1994 Oct; 18(5):1187-9. PubMed ID: 7847604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of naltrexone on mood and cognitive functioning among overweight men.
    Hatsukami DK; Mitchell JE; Morley JE; Morgan SF; Levine AS
    Biol Psychiatry; 1986 Mar; 21(3):293-300. PubMed ID: 3947710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of hepatotoxicity of naltrexone in the treatment of alcoholism.
    Yen MH; Ko HC; Tang FI; Lu RB; Hong JS
    Alcohol; 2006 Feb; 38(2):117-20. PubMed ID: 16839858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of long-term therapy with naltrexone on body weight in obesity.
    Atkinson RL; Berke LK; Drake CR; Bibbs ML; Williams FL; Kaiser DL
    Clin Pharmacol Ther; 1985 Oct; 38(4):419-22. PubMed ID: 4042525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstones.
    Marks JW; Sue SO; Pearlman BJ; Bonorris GG; Varady P; Lachin JM; Schoenfield LJ
    J Clin Invest; 1981 Nov; 68(5):1190-6. PubMed ID: 7298846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia.
    Mitchell JE; Christenson G; Jennings J; Huber M; Thomas B; Pomeroy C; Morley J
    J Clin Psychopharmacol; 1989 Apr; 9(2):94-7. PubMed ID: 2656781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of weight reduction on serum transaminase activities in children with simple obesity.
    Tazawa Y; Noguchi H; Nishinomiya F; Takada G
    J Pediatr; 1996 Apr; 128(4):587-8. PubMed ID: 8618202
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of naltrexone on senile dementia of the Alzheimer type.
    Hyman BT; Eslinger PJ; Damasio AR
    J Neurol Neurosurg Psychiatry; 1985 Nov; 48(11):1169-71. PubMed ID: 3001233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.